{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:17:57Z","timestamp":1791339477413,"version":"4.3.1"},"reference-count":39,"publisher":"National Academy of Sciences","issue":"37","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["20fk0108257h0001"],"award-info":[{"award-number":["20fk0108257h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["20fk0108510h0001"],"award-info":[{"award-number":["20fk0108510h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine","doi-asserted-by":"publisher","award":["20A2001D"],"award-info":[{"award-number":["20A2001D"]}],"id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine","doi-asserted-by":"publisher","award":["22A2009D"],"award-info":[{"award-number":["22A2009D"]}],"id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN261200800001E"],"award-info":[{"award-number":["HHSN261200800001E"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2024,9,10]]},"abstract":"<jats:p>\n                    We generated SARS-CoV-2 variants resistant to three SARS-CoV-2 main protease (M\n                    <jats:sup>pro<\/jats:sup>\n                    ) inhibitors (nirmatrelvir, TKB245, and 5h), by propagating the ancestral SARS-CoV-2\n                    <jats:sup>WK521<\/jats:sup>\n                    <jats:sub>WT<\/jats:sub>\n                    in VeroE6\n                    <jats:sup>TMPRSS2<\/jats:sup>\n                    cells with increasing concentrations of each inhibitor and examined their structural and virologic profiles. A predominant E166V-carrying variant (SARS-CoV-2\n                    <jats:sup>WK521<\/jats:sup>\n                    <jats:sub>E166V<\/jats:sub>\n                    ), which emerged when passaged with nirmatrelvir and TKB245, proved to be resistant to the two inhibitors. A recombinant SARS-CoV-2\n                    <jats:sub>E166V<\/jats:sub>\n                    was resistant to nirmatrelvir and TKB245, but sensitive to 5h. X-ray structural study showed that the dimerization of M\n                    <jats:sup>pro<\/jats:sup>\n                    was severely hindered by E166V substitution due to the disruption of the presumed dimerization-initiating Ser1\u2019-Glu166 interactions. TKB245 stayed bound to M\n                    <jats:sup>pro<\/jats:sup>\n                    <jats:sub>E166V<\/jats:sub>\n                    , whereas nirmatrelvir failed. Native mass spectrometry confirmed that nirmatrelvir and TKB245 promoted the dimerization of M\n                    <jats:sup>pro<\/jats:sup>\n                    , and compromised the enzymatic activity; the Ki values of recombinant M\n                    <jats:sup>pro<\/jats:sup>\n                    <jats:sub>E166V<\/jats:sub>\n                    for nirmatrelvir and TKB245 were 117\u00b13 and 17.1\u00b11.9 \u00b5M, respectively, indicating that TKB245 has a greater (by a factor of 6.8) binding affinity to M\n                    <jats:sup>pro<\/jats:sup>\n                    <jats:sub>E166V<\/jats:sub>\n                    than nirmatrelvir. SARS-CoV-2\n                    <jats:sup>WK521<\/jats:sup>\n                    <jats:sub>WT<\/jats:sub>\n                    selected with 5h acquired A191T substitution in M\n                    <jats:sup>pro<\/jats:sup>\n                    (SARS-CoV-2\n                    <jats:sup>WK521<\/jats:sup>\n                    <jats:sub>A191T<\/jats:sub>\n                    ) and better replicated in the presence of 5h, than SARS-CoV-2\n                    <jats:sup>WK521<\/jats:sup>\n                    <jats:sub>WT<\/jats:sub>\n                    . However, no significant enzymatic or structural changes in M\n                    <jats:sup>pro<\/jats:sup>\n                    <jats:sub>A191T<\/jats:sub>\n                    were observed. The replicability of SARS-CoV-2\n                    <jats:sup>WK521<\/jats:sup>\n                    <jats:sub>E166V<\/jats:sub>\n                    proved to be compromised compared to SARS-CoV-2\n                    <jats:sup>WK521<\/jats:sup>\n                    <jats:sub>WT<\/jats:sub>\n                    but predominated over SARS-CoV-2\n                    <jats:sup>WK521<\/jats:sup>\n                    <jats:sub>WT<\/jats:sub>\n                    in the presence of nirmatrelvir. The replicability of SARS-CoV-2\n                    <jats:sup>WK521<\/jats:sup>\n                    <jats:sub>A191T<\/jats:sub>\n                    surpassed that of SARS-CoV-2\n                    <jats:sup>WK521<\/jats:sup>\n                    <jats:sub>WT<\/jats:sub>\n                    in the absence of 5h, confirming that A191T confers enhanced viral fitness. The present data should shed light on the understanding of the mechanism of SARS-CoV-2\u2019s drug resistance acquisition and the development of resistance-repellant COVID-19 therapeutics.\n                  <\/jats:p>","DOI":"10.1073\/pnas.2404175121","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T14:32:13Z","timestamp":1725546733000},"update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":21,"title":["Structural and virologic mechanism of the emergence of resistance to M\n                    <sup>pro<\/sup>\n                    inhibitors in SARS-CoV-2"],"prefix":"10.1073","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5637-3397","authenticated-orcid":false,"given":"Shin-ichiro","family":"Hattori","sequence":"first","affiliation":[{"name":"Department of Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo 162-8655, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0262-6296","authenticated-orcid":false,"given":"Haydar","family":"Bulut","sequence":"additional","affiliation":[{"name":"Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, NIH, Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5892-0040","authenticated-orcid":false,"given":"Hironori","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, International Research Institute of Disaster Science, Tohoku University, Miyagi 980-8575, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kishimoto","sequence":"additional","affiliation":[{"name":"Department of Environmental and Molecular Health Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto 862-0973, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7173-240X","authenticated-orcid":false,"given":"Nobutoki","family":"Takamune","sequence":"additional","affiliation":[{"name":"Department of Environmental and Molecular Health Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto 862-0973, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0331-1624","authenticated-orcid":false,"given":"Kazuya","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Structural Biology Division, Japan Synchrotron Radiation Research Institute, Hyogo 679-5198, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Furusawa","sequence":"additional","affiliation":[{"name":"Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan"},{"name":"The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo 162-8655, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiya","family":"Yamayoshi","sequence":"additional","affiliation":[{"name":"Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan"},{"name":"The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo 162-8655, Japan"},{"name":"International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1749-4038","authenticated-orcid":false,"given":"Kazutaka","family":"Murayama","sequence":"additional","affiliation":[{"name":"Division of Biomedical Measurements and Diagnostics, Graduate School of Biomedical Engineering, Tohoku University, Miyagi 980-8575, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2788-2579","authenticated-orcid":false,"given":"Hirokazu","family":"Tamamura","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo 101-0062, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Structural Biology, National Cancer Institute, Frederick, MD 21702"},{"name":"Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5510-9703","authenticated-orcid":false,"given":"Alexander","family":"Wlodawer","sequence":"additional","affiliation":[{"name":"Center for Structural Biology, National Cancer Institute, Frederick, MD 21702"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5061-8296","authenticated-orcid":false,"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[{"name":"Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan"},{"name":"The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo 162-8655, Japan"},{"name":"Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin\u2013Madison, Madison, WI 53711"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Misumi","sequence":"additional","affiliation":[{"name":"Department of Environmental and Molecular Health Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto 862-0973, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Mitsuya","sequence":"additional","affiliation":[{"name":"Department of Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo 162-8655, Japan"},{"name":"Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, NIH, Bethesda, MD 20892"},{"name":"Department of Clinical Sciences, Kumamoto University Hospital, Kumamoto 860-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"publisher","DOI":"10.35772\/ghm.2020.01040"},{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001282"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00412-X"},{"key":"e_1_3_4_4_2","first-page":"100243","article-title":"Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE - Coalition V): A double-blind, multicentre, randomised, controlled trial","volume":"11","author":"Avezum A.","year":"2022","unstructured":"A. Avezum , Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE - Coalition V): A double-blind, multicentre, randomised, controlled trial. Lancet Reg. Health Am. 11, 100243 (2022).","journal-title":"Lancet Reg. Health Am."},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2118542"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl4784"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104559"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105247"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac769"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100735"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29104-y"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05514-2"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.3c00538"},{"key":"e_1_3_4_14_2","unstructured":"FDA Fact sheet for healthcare providers: Emergency use authorization for Paxlovid. https:\/\/www.fda.gov\/media\/155050\/download. Accessed 16 August 2024."},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.103004"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06609-0"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add7197"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36729-0"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-20900-6"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c00777"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01833-20"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13109"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104561"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pep.2022.106208"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102023"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M108005200"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.7.5356-5363.1999"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq7360"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.3c00054"},{"key":"e_1_3_4_30_2","doi-asserted-by":"crossref","unstructured":"E. M. Lewandowski Distal protein-protein interactions contribute to SARS-CoV-2 main protease substrate binding and nirmatrelvir resistance. bioRxiv [Preprint] (2024). https:\/\/doi.org\/10.1101\/2024.04.01.587566 (Accessed 24 June 2024).","DOI":"10.1101\/2024.04.01.587566"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.66.8.4647-4653.1992"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00967-10"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2002589117"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239403"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1107\/S2059798317017235"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444913015308"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444909042589"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444911001314"},{"key":"e_1_3_4_39_2","unstructured":"S.-i. Hattori SARS-CoV-2 Sequencing. NCBI-SRA BioProject. https:\/\/www.ncbi.nlm.nih.gov\/bioproject?LinkName=sra_bioproject&from_uid=31566696. Deposited 7 December 2023."}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.2404175121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T14:33:47Z","timestamp":1725546827000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/10.1073\/pnas.2404175121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":39,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2024,9,10]]}},"alternative-id":["10.1073\/pnas.2404175121"],"URL":"https:\/\/doi.org\/10.1073\/pnas.2404175121","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"2024-03-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2404175121"}}